The Equality Trap: Contested Horizons of Linguistic Justice Within and Beyond Discourses of (In)Equality
Journal of Sociolinguistics · 2026-11 · 30 (5) · 738-743
DOI: 10.1111/josl.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sociolinguistics, online erschienen am 14.11.2026. Verfasst von Jonathan Rosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Concepts such as equality and equity are often stereotypically associated with progress toward the creation of fairer and more just societies. However, the articles in this thematic series point to the need to interrogate how discourses of equality and equity can contribute to the reproduction of marginalization. This commentary enters into dialogue with these articles by examining how they each reveal various dimensions of the equality trap. By studying discourses of (in)equality in context, we learn how social actors become ensnared by the equality trap on the one hand, as well as how they contest and evade it on the other. The comments that follow are framed around three central themes that emerge throughout these articles: (1) the politics of minoritized legibility and erasure; (2) indexical orders of sociolinguistic justice; and (3) contested linguistic equalities of form, practice, and lived experience.
Zitieren
APA
Rosa, J. (2026). The Equality Trap: Contested Horizons of Linguistic Justice Within and Beyond Discourses of (In)Equality. Journal of Sociolinguistics, 30(5), 738-743. https://doi.org/10.1111/josl.70071
Vancouver
Rosa J. The Equality Trap: Contested Horizons of Linguistic Justice Within and Beyond Discourses of (In)Equality. Journal of Sociolinguistics. 2026;30(5):738-743. doi:10.1111/josl.70071
BibTeX
@article{Rosa2026,
author = {Rosa, Jonathan},
title = {The Equality Trap: Contested Horizons of Linguistic Justice Within and Beyond Discourses of (In)Equality},
journal = {Journal of Sociolinguistics},
year = {2026},
volume = {30},
number = {5},
pages = {738--743},
doi = {10.1111/josl.70071}
}
EUVIMED